Dexamethasone /kg
PreclinicalSmall molecule
Dexamethasone /kg is one of 10 small molecule programs targeting Cellulitis. It is currently in Preclinical.
1
Indications
5
Total Trials
2
Active Trials
9
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
10 competitors in Cellulitis
#DrugCompanyPhaseTrials
1Keflex
Eli LillyApproved
Acanya
PfizerApproved
Avelox
BayerApproved
Vancocin
HHikma Pharmaceuticals LLC
Approved
Cubicin
BBaxter Healthcare Corporation
Approved
Levaquin
WWim Janssens
Approved
Ancef
BBaxter Healthcare Corporation
Approved
Decadron
AAspen Global Incorporated
Preclinical
Trimethoprim-Sulfamethoxazole
AstellasPreclinical
Dexamethasone /kg
NNorthwestern University
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Cellulitis1 trial
Multimodal Analgesia1 trial
Post Spinal Anesthesia Shivering1 trial
The Effect of Different Doses of Dexamethasone on Post Spinal Anesthesia Shivering
Not yet recruiting·—·N/A·NCT06999070·150 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Dexamethasone /kg. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- NNorthwestern University